Join
Live feed
·
PRReleasevia Quantisnow
LifeMD Inc. logo

LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection

ByQuantisnow·Wall Street's wire, on your screen.
LFMD· LifeMD Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LFMD (LifeMD Inc.) and more on Quantisnow.